{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:15:46Z","timestamp":1792016146151,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":5344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1093\/annonc\/mdi915","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T19:34:45Z","timestamp":1117222485000},"page":"iv90-iv94","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S4","title":["FDG-PET in the management of germ cell tumor"],"prefix":"10.1016","volume":"16","author":[{"given":"U.","family":"De Giorgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fiorentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marangolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdi915_bb0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2004.05.006","article-title":"Germ cell tumours of the testis","volume":"53","author":"Gori","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdi915_bb0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/1097-0142(20010401)91:7<1304::AID-CNCR1133>3.0.CO;2-A","article-title":"Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era","volume":"91","author":"Sonneveld","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdi915_bb0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/107327480200900408","article-title":"Positron emission tomography in urologic oncology","volume":"9","author":"Shvarts","year":"2002","journal-title":"Cancer Control"},{"key":"10.1093\/annonc\/mdi915_bb0025","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mdh301","article-title":"European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)","volume":"15","author":"Schmoll","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/annonc\/mdf032","article-title":"Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer\u2013a necessary risk?","volume":"13","author":"Harvey","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0035","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1200\/JCO.2003.01.094","article-title":"Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review","volume":"21","author":"Vergouwe","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1054\/bjoc.2000.1389","article-title":"Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse","volume":"83","author":"Hain","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdi915_bb0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1464-410X.2002.02641.x","article-title":"The role of (18)-fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours","volume":"89","author":"Spermon","year":"2002","journal-title":"Brit J Urol Int"},{"key":"10.1093\/annonc\/mdi915_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000048442","article-title":"Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors","volume":"68","author":"Tsatalpas","year":"2002","journal-title":"Urol Int"},{"key":"10.1093\/annonc\/mdi915_bb0055","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s002590050547","article-title":"Fluorodeoxyglucose PET in the initial staging of germ cell tumours","volume":"27","author":"Hain","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1093\/annonc\/mdi915_bb0060","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0090-4295(98)00576-7","article-title":"Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors","volume":"53","author":"Albers","year":"1999","journal-title":"Urology"},{"key":"10.1093\/annonc\/mdi915_bb0065","unstructured":"National Cancer Institute Clinical Trials. Available from: http:\/\/www.nci.nih.gov\/search\/ViewClinicalTrialsaspx?cdrid=256314&version=patient&protocolsearchid=1434689. Accessed March 2005."},{"key":"10.1093\/annonc\/mdi915_bb0070","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1046\/j.1464-410X.2002.02779.x","article-title":"18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse","volume":"89","author":"Sanchez","year":"2002","journal-title":"Brit J Urol Int"},{"key":"10.1093\/annonc\/mdi915_bb0075","first-page":"1190","article-title":"Fluorodeoxyglucose (FDO) positron emission tomography (PET) in testicular germ cell tumors in adults: preliminary French clinical evaluation, development of the technique and its clinical applications","volume":"10","author":"Maszelin","year":"2000","journal-title":"Prog Urol"},{"issue":"Suppl 4","key":"10.1093\/annonc\/mdi915_bb0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/annonc\/mdf664","article-title":"The value of positron emission tomography (PET) imaging in disease staging and therapy assessment","volume":"13","author":"Jerusalem","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0085","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1023\/A:1012548312538","article-title":"PET and LAP in suspected testicular cancer relapse: beware sarcoidosis","volume":"12","author":"Karapetis","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0090","first-page":"361","article-title":"Sarcoidosis and testicular carcinoma","volume":"83","author":"Rayon","year":"1998","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdi915_bb0095","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00003072-199610000-00004","article-title":"Normal thymic uptake of FDG on PET imaging","volume":"21","author":"Patel","year":"1996","journal-title":"Clin Nucl Med"},{"key":"10.1093\/annonc\/mdi915_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/mdg011","article-title":"Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin\u2019s disease","volume":"14","author":"Jerusalem","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0105","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s00259-004-1607-9","article-title":"Fluorinated tracers for imaging cancer with positron emission tomography","volume":"31","author":"Couturier","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1093\/annonc\/mdi915_bb0110","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1200\/JCO.2004.04.008","article-title":"Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors","volume":"22","author":"Fizazi","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0115","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/sj.bjc.6600122","article-title":"Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET","volume":"86","author":"Bokemeyer","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdi915_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00345-004-0403-2","article-title":"The role of positron emission tomography in germ cell cancer","volume":"22","author":"De Santis","year":"2004","journal-title":"World J Urol"},{"key":"10.1093\/annonc\/mdi915_bb0125","first-page":"3791","article-title":"3\u2032-deoxy-3\u2032-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography","volume":"63","author":"Barthel","year":"2003","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdi915_bb0130","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1200\/JCO.2004.05.205","article-title":"Mortality after cure of testicular seminoma","volume":"22","author":"Zagars","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0135","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0360-3016(92)90475-W","article-title":"Seminoma of the testis: Long-term beneficial and deleterious results of radiation","volume":"24","author":"Hanks","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdi915_bb0140","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.1999.17.11.3457","article-title":"Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma","volume":"17","author":"Ganjoo","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0145","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1200\/JCO.2001.19.17.3740","article-title":"Predictive Impact of 2\u201318 Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography for Residual Postchemotherapy Masses in Patients With Bulky Seminoma","volume":"19","author":"De Santis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0150","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2004.07.188","article-title":"2\u201318fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial","volume":"22","author":"De Santis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00345-003-0392-6","article-title":"The role of [(18)F] FDG-PET, CT\/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors\u2013prospects for management","volume":"22","author":"Pfannenberg","year":"2004","journal-title":"World J Urol"},{"key":"10.1093\/annonc\/mdi915_bb0160","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.urology.2004.07.024","article-title":"18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy","volume":"64","author":"Putra","year":"2004","journal-title":"Urology"},{"key":"10.1093\/annonc\/mdi915_bb0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1445-5994.2003.00456.x","article-title":"Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up","volume":"33","author":"Karapetis","year":"2003","journal-title":"Intern Med J"},{"key":"10.1093\/annonc\/mdi915_bb0170","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/cncr.10494","article-title":"Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma","volume":"94","author":"Kollmannsberger","year":"2002","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdi915_bb0175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/A:1008200425854","article-title":"Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors","volume":"8","author":"Hartmann","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0180","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0959-8049(97)00111-1","article-title":"Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET","volume":"33","author":"Nuutinen","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdi915_bb0185","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1200\/JCO.1996.14.5.1637","article-title":"Positron emission tomography evaluation of residual radiographic abnormalities in post-chemotherapy germ cell tumor patients","volume":"14","author":"Stephens","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi915_bb0190","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF00817273","article-title":"Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management","volume":"22","author":"Wilson","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1093\/annonc\/mdi915_bb0195","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1148\/radiology.211.1.r99ap16249","article-title":"Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling","volume":"211","author":"Sugawara","year":"1999","journal-title":"Radiology"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419415275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419415275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/16\/suppl_4\/iv90\/385481\/mdi915.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:50:52Z","timestamp":1589471452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419415275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":39,"alternative-id":["S0923753419415275"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdi915","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}